Novel method can restore sense of touch in human amputees

Image
IANS New York
Last Updated : Oct 27 2016 | 5:32 PM IST

US scientists have in a breakthrough research found that realistic sensations of touch can be restored in human amputees by directly stimulating the nervous system.

In the study, neuroscientists from the University of Chicago used neuroprosthetic devices to turn the pressure "felt" by a prosthetic hand into a signal that feeds directly into the parts of the brain that deal with hand movement and touch.

"If you want to create a dexterous hand for use in an amputee or a quadriplegic patient, you need to not only be able to move it, but have sensory feedback from it," said Sliman Bensmaia, Associate Professor at the University of Chicago.

"The idea is that if we can reproduce natural-feeling sensations exactly, the amputee won't have to think about it, he can just interact with objects naturally and automatically," Bensmaia added.

The team worked with two male subjects who each lost an arm after traumatic injuries.

Both subjects were implanted with neural interfaces, devices embedded with electrodes that were attached to the median, ulnar and radial nerves of the arm.

Those are the same nerves that would carry signals from the hand were still intact, the researchers said.

The results showed that a single feature of electrical stimulation -- dubbed the activation charge rate -- can determine the strength of the sensation -- such as intensity discrimination, magnitude scaling, and intensity matching.

By changing the activation charge rate, the team could change sensory magnitude in a highly predictable way.

By modulating the number of nerve fibres stimulated and the frequency of stimulation, sensory information could be transmitted such that the amputees could distinguish distinct levels of tactile intensity, that is, the difference between a seven and a 10 on a scale of intensity.

However, these artificial touch will only be as good as the devices providing input, the researchers stated.

The study was published in the journal Science Translational Medicine.

--IANS

rt/ask/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 27 2016 | 5:26 PM IST

Next Story